OR WAIT null SECS
© 2022 MJH Life Sciences and Opthalmology Times Europe. All rights reserved.
© 2022 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
Global experts who manage patients with retinal disorders comment on current treatment barriers and highlight newer therapies and delivery systems coming to market.
August 9th 2021
A discussion highlighting new agents under investigation for retinal disorders and implications for future use based on data revealed in more recent clinical trials.
August 11th 2021
An overview of delivery systems under investigation for retinal disorders and implications for future use.
August 16th 2021
Considerations for treating retinal disorders with sustained-release drug delivery implants in an effort to address current treatment challenges in the field.
August 18th 2021
Dr Mariya Moosajee comments on the next generation of gene therapy for inherited retinal disease and highlights various systems under investigation.
August 23rd 2021
The impact of the COVID-19 pandemic on the management of patients with retinal disorders and considerations for how new practices may be adopted into future practice.
August 25th 2021
Key takeaways from a discussion on the management of age-related macular degeneration, diabetic macular edema, and inherited retinal disease and insight regarding what to look forward to as the field advances.